Dr James Waisman is one of the pre-eminent breast oncologists in the United States. Trained as a medical oncologist, he began to sub-specialize in breast cancer in the mid-1980s at the Van Nuys Breast Center in Los Angeles. He and his colleague Melvin Silverstein, MD did some of the pioneering work on the management of ductal carcinoma in situ (DCIS). He has authored or co-authored 40 peer-reviewed articles, 60 abstracts and 12 books or book chapters.

He has also been a presenter at the San Antonio Breast Cancer Symposium. Over the past several years, Dr. Waisman has lectured at community forums sharing the newest breast cancer breakthroughs reported at this symposium. He is accompanied by advocates who attended the symposium with him.

In 1998 he left the Van Nuys Breast Center, which was one of the paramount private breast centers in the United States, to go to the University of Southern California, where he became head of translational research for breast cancer at the USC Norris Cancer Center. In 2002 he joined Breastlink Medical Group, Inc and currently is the Vice President of Breastlink Medical Group, Inc. and Director of Translational Medicine at the Barbara K. Robinson Breast Cancer Research Program. He directs the
collaboration with the University of Washington Vaccine Program.

James Waisman, MD is known for his compassion and his commitment to patient care, treating each woman as an individual. He is beloved by his patients and their families. Dr. Waisman is also a superb teacher. The recipients of his teaching are principally his patients but also his medical students and his fellow staff and physicians.